PharmabizOpinion

KPRDO urges state govt to frame State Rules for incorporating sections in D&C Rules

Nandita Vijayasimha, Bengaluru Friday, December 26, 2025, 08:00 Hrs [IST] ...
Pharmabiz

Symbiosis Pharmaceutical Services begins commercial production at its new US FDA-inspected facility in Stirling

Symbiosis Pharmaceutical Services begins commercial production at its new US FDA-inspected facility in Stirling: Stirling, Scotland Friday, December 26, 2025, 18:00 Hrs [IST] Symb ...
Pharmabiz

Telangana DCA busts unlicensed medical device unit in Sangareddy, stocks worth Rs. 1.70 lakhs seized

Telangana DCA busts unlicensed medical device unit in Sangareddy, stocks worth Rs. 1.70 lakhs seized: Peethaambaran Kunnathoor, Chennai Friday, December 26, 2025, 09:00 Hrs [IST] ...
Pharmabiz

US FDA approves Edwards Lifesciences' SAPIEN M3 mitral valve replacement system, a first transseptal transcatheter therapy to treat mitral regurgitation

Irvine, California Friday, December 26, 2025, 11:00 Hrs [IST] ...
Pharmabiz

Nona Biosciences expands integrated discovery-to-clinical capabilities through strategic platform growth

Nona Biosciences expands integrated discovery-to-clinical capabilities through strategic platform growth: Cambridge, Massachusetts Friday, December 26, 2025, 12:00 Hrs [IST] Nona ...
Pharmabiz

Agios Pharma’s oral PK activator, Aqvesme receives US FDA approval to treat anaemia in adults with alpha- or beta-thalassemia

Agios Pharma’s oral PK activator, Aqvesme receives US FDA approval to treat anaemia in adults with alpha- or beta-thalassemia: Cambridge, Massachusetts Friday, December 26, 2025 ...
Pharmabiz

Amneal Pharma receives US FDA approval for denosumab biosimilars Prolia and Xgeva

Amneal Pharma receives US FDA approval for denosumab biosimilars Prolia and Xgeva: Bridgewater, New Jersey Friday, December 26, 2025, 16:00 Hrs [IST] Bridgewater headquartered Amn ...
Pharmabiz

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis: Paris Friday, December 26, 2025, 13:00 Hrs [IST] The US Foo ...
Pharmabiz

IRLAB receives approval for phase Ib study with IRL757 in Parkinson’s disease

IRLAB receives approval for phase Ib study with IRL757 in Parkinson’s disease: Gothenburg, Sweden Friday, December 26, 2025, 17:00 Hrs [IST] Sweden headquartered IRLAB, a compan ...
Pharmabiz

AB Science receives US patent for masitinib to treat sickle cell disease

AB Science receives US patent for masitinib to treat sickle cell disease: Paris Friday, December 26, 2025, 14:00 Hrs [IST] AB Science SA, a pharmaceutical company specializing in ...
Pharmabiz

Sanofi to acquire vaccines company Dynavax Technologies

Sanofi announced that it has entered into an agreement to acquire Dynavax Technologies Corporation (Dynavax), a publicly traded vaccines company with a marketed adult hepatitis B vaccine (Heplisav-B) ...
Pharmabiz

Pharmaceutical firms must prioritize AI integration, supply resilience to thrive in 2026: Nikkhil Masurkar

Pharmaceutical firms must prioritize AI integration, supply resilience to thrive in 2026: Nikkhil Masurkar: Shardul Nautiyal, Mumbai Friday, December 26, 2025, 08:00 Hrs [IST] Pha ...